Skip to main content
. 2016 Jul 1;21(10):1165–1175. doi: 10.1634/theoncologist.2016-0097

Figure 2.

Figure 2.

Risk difference for AEs (hematologic laboratory and nonhematologic: all cycles, as treated). a“Infections” includes any reported preferred terms that are part of the system organ class of infections and infestations. b“Rash” includes the following preferred terms: “rash,” “rash maculo-papular,” “rash pruritic,” “rash erythematous,” “rash papular,” “dermatitis,” and “dermatitis acneiform.”

Abbreviations: AE, adverse event; CI, confidence interval.